Market revenue in 2023 | USD 149.2 million |
Market revenue in 2030 | USD 290.2 million |
Growth rate | 10% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Brazil mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Brazil holds a major share of the mRNA therapeutics contract development & manufacturing organization (CDMO) market in Latin America and is expected to maintain its dominance over the forecast period.
Among the Latin American countries, clinical trials are mostly conducted in Brazil owing to its cost-effectiveness, high prevalence of diseases, and ease of patient recruitment. Due to the rapidly growing demand for mRNA vaccines, there is a rising number of trials being conducted in this region, which is expected to drive market growth during the forecast period.
Increasing R&D capabilities and initiatives among global companies are likely to attract investments from pharmaceutical & biotech companies. This is expected to boost market growth during the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Brazil mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account